Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Advances in Cardiac Amyloidosis

    Contains 1 Component(s) Includes a Live Event on 10/10/2019 at 12:00 AM (EDT)

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.  

    Advances in Cardiac Amyloidosis

    Moderators: Dr. Diana Paez and Dr. Prem Soman

    • Introduction: Diana Paez, MD
    • Diagnosis of Cardiac Amyloidosis: ASNC/Multisocietal Consensus Recommendations: Sharmila Dorbala, MD, FASNC 
    • 99mTc-Bone Tracer Imaging for ATTR Cardiac Amyloidosis: Professor, dr. Riemer Slart, MD, PhD 
    • Novel Treatments for ATTR Cardiac Amyloidosis: Professer Claudio Rapezzi, MD
    • Discussion: Dr. Prem Soman

    Faculty:

    Sharmila Dorbala, MD, MPH, FASNC
    Director, Nuclear Cardiology
    Brigham and Women's Hospital, Boston, Massachusetts

    Prem Soman, MD, PhD, MASNC
    Associate Professor of Medicine (Cardiology) and Clinical & Translational Science
    Director, Nuclear Cardiology
    Director, Multidisciplinary Cardiac Amyloidosis Center
    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

    Diana Paez, MD 
    Section Head |Nuclear Medicine and Diagnostic Imaging Section 
    Division of Human Health | Department of Nuclear Sciences and Applications 
    International Atomic Energy Agency (IAEA), Vienna, Austria

    Professor Claudio Rapezzi, MD 
    Associate Professor
    Department of Experimental, Diagnostic and Specialty Medicine - DIMES
    University of Bologna, Bologna, Italy

    Professor,dr. R.H.J.A. (Riemer) Slart 
    Faculty of Medical Sciences
    University Medical Center Groningen, Groningen, Netherlands

    No CME or CE credit is provided.

  • IAEA-ASNC webinar on Heart Failure

    Contains 1 Component(s) Recorded On: 02/14/2019

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the first in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the first in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.  

    Myocardial Perfusion Imaging Assessment of LV Mechanical Dyssynchrony to Guide Treatment in patients in Heart Failure

    The first part of the webinar will provide an overview of established and exciting, new applications of radionuclide imaging in heart failure. In the second part the speaker will describe how ECG-gated Myocardial Perfusion SPECT imaging is used to measure the regional onset of mechanical contraction as an indicator of LV intraventricular dyssynchrony (LVD). The session will also address how biventricular pacemakers are being used to treat systolic heart failure in patients with advanced left bundle branch block using Cardiac Resynchronization Therapy (CRT) and the role that LVD plays in predicting CRT response and assessing treatment. The potential of this use of LVD will be discussed under the results of the IAEA funded VISION-CRT study.

    Faculty:

    Prem Soman, MD, PhD, MASNC
    Associate Professor of Medicine (Cardiology) and Clinical & Translational Science
    Director, Nuclear Cardiology
    Director, Multidisciplinary Cardiac Amyloidosis Center
    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

    Ernest V. Garcia, PhD, MASNC
    Professor of Radiology and Imaging Sciences
    Director, Emory Nuclear Cardiology R&D Laboratory
    Emory University Hospital, Atlanta, Georgia 

    No CME or CE credit is provided.

  • Best Practices for Technologists

    Contains 1 Component(s) Recorded On: 06/21/2018

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars on Wednesday, June 20th at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    Faculty:

    E. Gordon DePuey, M.D., MASNC
    Director of Nuclear Medicine, Mount Sinai St. Luke's and West Hospitals
    Clinical Professor of Radiology, Icahn School of Medicine at Mount Sinai New York, NY

    Jereme Morley, CNMT, R.T. (CT)
    Chief Technologist, Nuclear Medicine, Mount Sinai St. Luke's Hospital New York, NY

    No CME or CE credit is provided.

  • Quality & Nuclear Cardiology: Importance to Technologists

    Contains 1 Component(s) Recorded On: 04/26/2018

    ASNC is pleased to offer a webinar for technologists on Quality & Nuclear Cardiology: Importance to Technologists. Attendees will be provided an understanding of what quality means in the current healthcare environment.

    ASNC is pleased to offer a webinar for technologists on Quality & Nuclear Cardiology: Importance to Technologists. Attendees will be provided an understanding of what quality means in the current healthcare environment.

    Objectives:
    This informative 60-minute webinar will help you:

    1.       Discuss the basic principles and theory of quality in healthcare
    2.       Discuss how quality is applied to imaging procedures
    3.       Discuss the humanistic factors affecting quality
    4.       Discuss the role of the nuclear medicine technologist in achieving a high quality interpretable image to drive patient care, outcomes and treatment

    Audience:
    This webinar is designed for imaging professionals interested in the best practices and latest research available in the field of nuclear cardiology.

    Program Chair
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS

    System Quality Manager
    Heart and Vascular Institute
    Hartford Healthcare Corporation
    Hartford, CT

    Planners
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS
    Wendy Passerell, ASNC Staff

    Reviewer
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS

    Disclosure Policy
    As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s 2004 Standards for Commercial Support.  In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationship with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers and presenters involved with this activity were required to disclose any relevant financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer review process.

    The following faculty planners, reviewers, editors, question writers and staff reported the following financial relationships:
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS, Chair, Consulting – Jubilant DraxImage; Honoraria – Jubilant DraxImage, Astellas; Advisory Board – Astellas; Speaker’s Bureau – Astellas.

    The following faculty planners, reviewers, editors, question writers and staff reported no financial relationships:
    Wendy Passerell, ASNC staff

    Off Label Use
    Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented.  Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

    Accreditation and Continuing Education Credit

    Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This enduring activity has been approved for a maximum of 1 ARRT Category A credits for Technologists.

    Processing Fees
    ASNC members may claim continuing education credits at no charge.  Non-members will be charged $25.00 per activity.

    Method of Participation
    This enduring material is a 60-minute webinar. In order to be eligible for CE credit, you must listen to the webinar, reflect on the material and respond to the post-test. A score of 75% or higher is needed to pass the post-test. After successfully completing the activity, post-test and evaluation form, users will be able to generate an CE certificate.

    It is estimated that this activity will take 1 hour to complete.

    This is available as an online activity with audio synchronized with PowerPoint presentations.

    Policy of Privacy and Confidentiality
    ASNC will record learner’s personal information as provided on CE evaluations to allow for issuance and tracking of CE certificates. ASNC may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CE program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

    ASNC Copyright Information
    Please see the “Terms of Use” at the bottom of any asnc.org web page.

    Acknowledgement of Commercial Support
    This activity does not have commercial support.

    Learners’ Bill of Rights
    Please click to access Learners’ Bill of Rights.

    Contact Information
    For technical assistance or information, please contact CECity at lifetimesupport@premierinc.com

    For questions regarding content or obtaining CE credit, please contact the American Society of Nuclear Cardiology at info@asnc.org.

  • Cardio-Oncology: Therapeutic and diagnostic considerations of radiation exposure in breast cancer

    Contains 1 Component(s) Recorded On: 04/12/2018

    This webinar will review the concerns about cardiac complications of cancer therapy from the viewpoint of the oncologist and cardiologist. The discussion will specifically focus on the diagnostic and therapeutic uses of radiation and radionuclides in the care of cancer patients.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the first in a series of complimentary webinars on Wednesday, April 11th at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    Learning Objectives:                                                                                                                                                                            

    This webinar will review the concerns about cardiac complications of cancer therapy from the viewpoint of the oncologist and cardiologist. The discussion will specifically focus on the diagnostic and therapeutic uses of radiation and radionuclides in the care of cancer patients. 


    Faculty:  

    Raymond Russell, III, MD, PhD, MASNC
    Lifespan Cardiovascular Institute, Providence, RI
    Director, Nuclear Cardiology and Clinical Cardiology Fellowship Program

    Maysa Abu-Khalaf, MD
    Associate Professor of Medical Oncology
    Director, Breast Medical Oncology
    Co-Director, Jefferson Breast Care Center
    Sidney Kimmel Cancer Center at Jefferson

    No CME or CE credit is provided.

  • ASNC Advocacy: Quality Payment Program - What you need to know for 2018

    Contains 1 Component(s) Recorded On: 01/31/2018

    ASNC will provide an update to changes for CY2018 in the Merit Based Incentive Payment System and other provisions of the Quality Payment rule.

    Some of the rules for participating in the Quality Payment Program for 2018 have changed.  Learn what you need to know to avoid a negative payment update and how you could possibly earn an incentive in 2020.   

    For physicians and group practices that choose to participate in the Quality Payment Program through the Merit-Based Incentive Payment System (MIPS) pathway, the webinar will feature an overview of ASNC’s ImageGuide which is a qualified reporting mechanism that nuclear cardiologists can use to fulfill the quality component of the MIPS. 

    Speakers: Camille Bonta, MHS, Summit Health Consulting and Joe Reyes, ASNC Specialist, ImageGuide

  • Coding for Myocardial Blood Flow in PET

    Contains 1 Component(s) Recorded On: 01/24/2018

    This webinar will instruct attendees on the importance of proper billing and coding for Quantitation of Myocardial Blood Flow. There will also be a review pertinent changes to the chargemaster and other payment information.

    ASNC is pleased to announce a new category III code for absolute quantitation of Myocardial Blood Flow in PET effective Jan. 1, 2018. This webinar will instruct attendees on the importance of proper billing and coding for Quantitation of Myocardial Blood Flow. There will also be a review of pertinent changes to the chargemaster and other payment information.

    Speaker: Denise Merlino, MBA, CNMT, CPC, President of Merlino Health Consulting

  • Nuclear Cardiology in the Arab World, Challenges and Opportunities

    Contains 1 Component(s) Recorded On: 10/10/2017

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the third in a series of complimentary webinars on Tuesday, October 10th 11:00 AM (ET) – 12:00 PM (ET). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the third in a series of complimentary webinars on Tuesday, October 10th 11:00 AM (ET) – 12:00 PM (ET). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians. 

    Webinar in Arabic and English on “Nuclear Cardiology in the Arab World, Challenges and Opportunities

    Faculty:

    Mouaz H. Al-Mallah, MD MSc, FASNC FACC FAHA FESC
    Associate Professor of Medicine
    Consultant Cardiologist and Division Head, Cardiac Imaging
    King Abdul-Aziz Cardiac Center
    King Abdul-Aziz Medical City (Riyadh)

    Adel H Allam, MD, FASNC
    Professor of Cardiology Al Azhar University
    Chief of Nuclear Cardiology Alfa Medical
    President of the Egyptian League of Cardiovascular Imaging

    No CME or CE credit is provided for this event.

  • Clinical Indications of PET for Myocardial Perfusion PET

    Contains 1 Component(s) Recorded On: 07/27/2017

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars on Wednesday, July 26 at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars on Wednesday, July 26 at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    Webinar on “Clinical Indications of PET for Myocardial Perfusion PET”


    Speakers:

    Timothy Bateman, MD
    St. Luke’s Health System, University of Missouri- Kansas City School of Medicine, Kansas City, MO.

    Gary V. Heller, MD, PhD
    Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ.

    James Case, PhD
    Cardiovascular Imaging Technologies,L.L.C., Kansas City, MO.  


    The session will be based on the American Society of Nuclear Cardiology and the Society of Nuclear Medicine and Molecular Imaging Position Statement on the Clinical Indications of PET for Myocardial Perfusion PET.  Attendees will increase their competency of myocardial perfusion PET and learn about the advantages of various PET imaging protocols.

    No CME or CE credit is provided for this event.


  • Elaboración de un informe de cardiología nuclear con SPECT o PET

    Contains 1 Component(s) Recorded On: 05/24/2017

    La sesión que tendremos se enfocará en la correcta elaboración de un informe, cumpliendo con los lineamientos, de un estudio de perfusión miocárdica y de viabilidad miocárdica.


    La sesión que tendremos se enfocará en la correcta elaboración de un informe, cumpliendo con los lineamientos, de un estudio de perfusión miocárdica y de viabilidad miocárdica.

    Respondiendo a las interrogantes del médico referente, destacaremos la importancia de un reporte bien estructurado con base en los resultados objetivos del estudio, tomando en cuenta el contexto clínico del paciente. Al término de la sesión, el usuario estará capacitado para:

    1.       Identificar y comprender los diferentes lineamientos utilizados para la correcta elaboración de un informe de SPECT/PET cardíaco con agentes de perfusión y de viabilidad miocárdica.

    2.       Comprender el significado de los diferentes parámetros cualitativos y cuantitativos de perfusión y función ventricular para su correcta inclusión en el reporte de modo organizado.

    3.       Integrar y reportar la información relevante para diagnóstico de isquemia o estratificación de riesgo en el paciente con enfermedad coronaria sospechada o conocida.

    4.       Integrar la información del estudio con el resultado de la prueba de estrés físico o farmacológico y con la situación clínica del paciente.

    5.       Entender la utilidad clínica de la reserva de flujo miocárdico y cómo incorporarlo en el reporte.

    6.       Integrar la información de la tomografía coronaria y del score de calcio con el análisis de la perfusión miocárdica.

    7.       Interpretar los resultados de una prueba de viabilidad miocárdica con agentes de perfusión y metabolismo.

    Dr. Erick Alexanderson                                          
    Presidente de la Sociedad Mexicana de Cardiología
    Jefe del Departamento de Cardiología Nuclear Instituto Nacional de Cardiología "Ignacio Chavez"

    Dr. Fernando Mut
    Director del Servicio de Medicina Nuclear, Hospital Asociacion Española
    Montevideo, Uruguay


    No CME or CE credit is provided for this event.